A federal judge’s decision to revoke the FDA’s approval of the abortion pill mifepristone has led some politicians to ask the Biden Administration not to enforce the ruling. Yet NARAL Pro-Choice America President Mini Timmaraju, who’s in close contact with the White House, tells “Conversations on Health Care” that’s not the right move. “I think calls for the FDA not to comply, while you know emotionally satisfying, are not actually helpful in a litigation strategy. And our goal is for the FDA and the DOJ to prevail in this case. The ruling…is riddled with serious disinformation.”
Timmaraju explains how the Supreme Court could hear the case by the end of this week and how this judge’s opinion could have an even bigger impact on the entire health care sector. Her interview with Mark Masselli and Margaret Flinter is online now.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Android | Podchaser | TuneIn | RSS | More
Originally broadcast June 5, 2024. A recent report from the Centers for Disease Control and…
Veterans Day, which is less than a month away, is a time to honor and…
Originally broadcast October 9, 2025 $44 billion in drugs that help Americans are purchased through…
Originally broadcast October 2, 2025 The federal government is shut down and the ripple effects…
Originally broadcast Tuesday, September 23, 2025 Happy anniversary to “Conversations on Health Care”! We posted…
Dr. Wayne Jonas, who formerly led the National Institutes of Health Office of Alternative Medicine,…